Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron

被引:3
作者
Zhu, Ka-Li [1 ,2 ]
Gao, Hui-Xia [3 ]
Yao, Lin [2 ]
Rong, Jun [3 ]
Yang, Li [3 ]
Zhang, Zhi [3 ]
Jiang, Ping [3 ]
Duan, Li-Jun [2 ]
Wang, Guo-Lin [2 ]
Dai, Er-Hei [3 ]
Ma, Mai-Juan [1 ,2 ]
机构
[1] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Peoples R China
[2] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dongda St, Beijing 100071, Peoples R China
[3] Hebei Med Univ, Hosp Shijiazhuang 5, Shijiazhuang, Hebei, Peoples R China
基金
北京市自然科学基金;
关键词
SARS-CoV-2; Delta infection; Omicron; vaccination; neutralization;
D O I
10.1093/infdis/jiac149
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant extensively escape neutralizing antibodies by vaccines or infection. We assessed serum neutralizing activity in sera from Delta infection after vaccination and Delta infection only against SARS-CoV-2 Wuhan-Hu-1 (WA1), Beta, Delta, and Omicron. Sera from Delta infection only could neutralize WA1 and Delta but almost completely lost capacity to neutralize Beta and Omicron. However, Delta infection after vaccination resulted in a significant increase of serum neutralizing activity against WA1, Beta, and Omicron. This study demonstrates that breakthrough infection of Delta substantially induced high potency humoral immune response against the Omicron variant and other emerged variants. The sera from patients with the Delta infection only had less neutralizing activity to the Omicron, whereas the sera from patients with Delta infection after vaccination displayed potent neutralization to the Omicron variant.
引用
收藏
页码:1551 / 1555
页数:5
相关论文
共 50 条
  • [21] Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants
    Chen, Luyi
    He, Ying
    Liu, Hongye
    Shang, Yongjun
    Guo, Guoning
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa
    Sokhela, Simiso
    Bosch, Bronwyn
    Hill, Andrew
    Simmons, Bryony
    Woods, Joana
    Johnstone, Hilary
    Madhi, Shabir
    Qavi, Ambar
    Ellis, Leah
    Akpomiemie, Godspower
    Bhaskar, Esther
    Levi, Jacob
    Falconer, Jonathan
    Mirchandani, Manya
    Casas, Carmen Perez
    Moller, Karlien
    Pilkington, Victoria
    Pepperrell, Toby
    Venter, Willem Daniel Francois
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (12):
  • [23] Safety of lung resection surgery after severe acute respiratory syndrome coronavirus 2 infection in the post-vaccination era
    Im, Somin
    Na, Kwon Joong
    Park, Ji Hyeon
    Na, Bubse
    Park, Samina
    Park, In Kyu
    Kang, Chang Hyun
    Kim, Young Tae
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (04)
  • [24] High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster
    Guirakhoo, Farshad
    Wang, Shixia
    Wang, Chang Yi
    Kuo, Hui-Kai
    Peng, Wen-Jiun
    Liu, Hope
    Wang, Lixia
    Johnson, Marina
    Hunt, Adam
    Hu, Mei Mei
    Monath, Thomas P.
    Rumyantsev, Alexander
    Goldblatt, David
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (08) : 1401 - 1406
  • [25] Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome
    Streng, Bianca M. M.
    Bont, Marin
    Delemarre, Eveline M.
    Binnendijk, Rob S.
    Smit, Gaby
    den Hartog, Gerco
    Coppus, Antonia M. W.
    de Vries, Esther
    Weijerman, Michel E.
    Lamberts, Regina
    de Graaf, Gert
    van der Klis, Fiona R.
    Vidarsson, Gestur
    Rave, Neele
    Bont, Louis J.
    Wildenbeest, Joanne G.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (04) : 673 - 677
  • [26] An Autopsy Case of Reversible Cerebral Vasoconstriction Syndrome After a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination
    Shimura, Mai
    Fujikawa, Hirohisa
    Yazawa, Masanobu
    Matsumoto, Yuki
    Yamada, Mitsunori
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [28] Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals
    Moy, James N.
    Anderson, Mark
    Shen, Xiaoying
    Fu, Jia
    Stec, Michael
    Gosha, Amy
    Naguiallah, Dina
    Kinslow, Jennifer
    Montefiori, David C.
    Cloherty, Gavin
    Landay, Alan
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (08) : 1407 - 1411
  • [29] Seizures in Children With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Lavisier, Begona de Miguel
    Gutierrez, Miguel Angel Molina
    Torrejon, Ruth Camila Pua
    Herrero, Maria Angeles Garcia
    Mesa, Maria Dolores Rodriguez
    Garcia, Marta Furones
    Lopez, Rosario Lopez
    Barriocanal, Marta Bueno
    Sanchez, Paula Garcia
    Dominguez, Jose Antonio Ruiz
    Lacalle, Maria de Ceano-Vivas
    PEDIATRIC NEUROLOGY, 2024, 157 : 151 - 156
  • [30] Effectiveness of first-generation severe acute respiratory syndrome coronavirus 2 mRNA vaccines against the Omicron variant
    Dagan, Noa
    Barda, Noam
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (12) : 1526 - 1527